OnLume
Madison, US · Founded 2015 · Wisconsin corporation
Founders & leadership
CG
Carl GulbrandsenNamed on SEC filing
BT
Benjamin TitzNamed on SEC filing
KW
Kevin W. EliceiriNamed on SEC filing
TR
Thomas R. MackieNamed on SEC filing
AJ
Adam J. UselmannNamed on SEC filing
AV
Andreas VeltenNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$11.1M disclosed across 4 rounds · 2019–2022
▶$2.8MraisedJan 2023 · 14 investors · Other Health CareRule 506(b)
▶$2.8MraisedJan 2023 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kevin W. EliceiriDirector
- Andreas VeltenDirector
- Michael LuzichDirector
- James A. BowmanExecutive Officer
- Adam J. UselmannExecutive Officer, Director
- Benjamin TitzDirector
- Thomas R. MackieDirector
- Offering amount
- $6M
- Amount sold
- $2.8M
- First sale
- Dec 2022
- Incorporated
- Corporation, Wisconsin
- Federal exemptions
- 06b
▶$6.6MraisedJan 2021 · 26 investors · Other Health CareRule 506(b)
▶$6.6MraisedJan 2021 · 26 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Carl GulbrandsenDirector
- Benjamin TitzDirector
- Kevin W. EliceiriDirector
- Thomas R. MackieDirector
- James A. BowmanExecutive Officer
- Andreas VeltenDirector
- Adam J. UselmannExecutive Officer, Director
- Offering amount
- $7.3M
- Amount sold
- $6.6M
- First sale
- Dec 2020
- Incorporated
- Corporation, Wisconsin
- Federal exemptions
- 06b
▶$364.6KraisedMar 2020 · 4 investors · Other Health CareRule 506(b)
▶$364.6KraisedMar 2020 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Andreas VeltenDirector
- Thomas R. MackieExecutive Officer, Director
- Kevin W. EliceiriDirector
- Benjamin TitzExecutive Officer, Director
- Carl GulbrandsenDirector
- Adam J. UselmannExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $364.6K
- First sale
- Feb 2020
- Incorporated
- Corporation, Wisconsin, 2015
- Federal exemptions
- 06b
▶$1.4MraisedAug 2019 · 10 investors · Other Health CareRule 506(b)
▶$1.4MraisedAug 2019 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Carl GulbrandsenDirector
- Benjamin TitzExecutive Officer, Director
- Kevin W. EliceiriDirector
- Thomas R. MackieExecutive Officer, Director
- Adam J. UselmannExecutive Officer, Director
- Andreas VeltenDirector
- Offering amount
- $1.4M
- Amount sold
- $1.4M
- Proceeds to insiders
- $54K
- First sale
- May 2019
- Incorporated
- Corporation, Wisconsin, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.9M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $300K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- How much funding has OnLume raised?
- OnLume has disclosed $11.1M raised across 4 rounds.
- Where is OnLume headquartered?
- OnLume is headquartered in Madison, US.